Connectyx Techs Hlds Inc (OP: CTYX )

0.0357 USD +0.0036 (+11.21%)

Official Closing Price Updated: 3:52 PM EST, Nov 24, 2020 Add to My Watchlist

Price and Volume

Volume	1,254,600
Open	0.0311
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0321
Today's Range	0.0300 - 0.0358
52wk Range	0.0001 - 0.0556
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Connectyx Announces Name Change to Curative Biotechnology and Secures Bridge Financing

November 23, 2020

Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma

October 16, 2020

Performance

YTD	+693.33%	+693.33%
1 Month	-7.99%	-7.99%
3 Month	+243.27%	+243.27%
6 Month	+283.87%	+283.87%
1 Year	+35600.00%	+35600.00%

More News

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

October 09, 2020

Connectyx Technologies Holdings Group, Inc. Announces Strategic Relationship with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

August 27, 2020

Connectyx in Licensing Discussions for Novel Monoclonal Antibody to Treat Pediatric Glioblastoma

July 06, 2020

Connectyx Welcomes I. Richard Garr, Esq. to Company’s Scientific Advisory Board

May 19, 2020

Connectyx Welcomes Dr. Michael Grace and Dr. Ronald Bordens to the Company’s Scientific Advisory Board

May 08, 2020

Connectyx Technologies Issues Shareholder Update

May 01, 2020

Connectyx Technologies Holdings Group Returns to OTC Current Status

April 13, 2020

Connectyx Announces Grant of License from National Institutes of Health for Use of Novel Monoclonal Antibody to Treat Glioblastoma

October 16, 2020

Connectyx Technologies Holdings Group, Inc. Announces Definitive Agreement with Mid-Atlantic BioTherapeutics, Inc. for Treatment of Symptomatic Rabies

October 09, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.